BioCentury
ARTICLE | Clinical News

IV rolapitant: Phase I started

October 7, 2013 7:00 AM UTC

Tesaro began an open-label, dose-escalation Phase I trial to evaluate IV rolapitant in healthy volunteers. An oral formulation of rolapitant is in Phase III testing to prevent CINV, with data expected...